Stay updated with breaking news from Conmed Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CONMED Co. (NYSE:CNMD – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven analysts that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target […]
CONMED Co. (NYSE:CNMD – Get Free Report) declared a quarterly dividend on Monday, February 26th, Wall Street Journal reports. Stockholders of record on Friday, March 15th will be paid a dividend of 0.20 per share on Friday, April 5th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.94%. The […]
Research Analysts’ price target changes for Thursday, February 1st: Align Technology (NASDAQ:ALGN) had its target price boosted by Piper Sandler from $290.00 to $335.00. The firm currently has an overweight rating on the stock. Aptose Biosciences (NASDAQ:APTO) (TSE:APS) had its price target trimmed by Piper Sandler from $12.00 to $5.00. They currently have an overweight […]
CONMED Co. (NYSE:CNMD – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price objective among […]
CONMED Co. (NYSE:CNMD – Get Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year target […]